Skip to content

Perceptions of De-implementing Routine Follow-ups After Hip and Knee Arthroplasty

How Do Patients and Health Care Professionals Perceive De-implementation of Routine Follow-ups After Total Hip and Knee Arthroplasty? Protocol for a Nested Qualitative Study Within a Hybrid De-implementation Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07041528
Acronym
HAKA-QUALI
Enrollment
90
Registered
2025-06-27
Start date
2026-09-01
Completion date
2028-06-01
Last updated
2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthroplasty, Total, Knee Arthroplasty, Total

Keywords

Aftercare, Arthroplasty, Focus Groups, Hip, Interview [Publication Type], Knee, Osteoarthritis, Patient Acceptance of Health Care, Qualitative Research

Brief summary

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guidelines. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up. The HAKA trial consists of three different work packages (WPs).The quantitative work packages 1 (WP1) and 2 (WP2) will investigate the 1-year and 10-year follow-up. The qualitative third work package (WP3) will explore and compare the patients' and health care professionals' (HCPs) experiences with, and perceptions about, RFU and COD after total hip and knee arthroplasty. The aim of the overarching HAKA-trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Interventions

None listed

Sponsors

Reinier Haga Orthopedisch Centrum
CollaboratorOTHER
JointResearch
CollaboratorOTHER
Tergooi Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• A good command of the Dutch language

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
The participants' experiences with their follow-up regimen.Experiences gained between the baseline clinical visit and a clinical visit one year later.The participants' experiences will be explored using a mix of semi-structured open-ended focus group questions.
The participants' satisfaction with their follow-up regimen.Perceived satisfaction between the baseline clinical visit and a clinical visit one year later.The participants' satisfaction will be explored using a mix of semi-structured open-ended focus group questions.
The health care professionals' experiences with the different follow-up regimens.Experiences gained between the baseline clinical visit and a clinical visit one year later.The health care professionals' experiences will be explored using a mix of semi-structured open-ended interview questions.
The health care professionals' satisfaction with the different follow-up regimens.Perceived satisfaction between the baseline clinical visit and a clinical visit one year later.The health care professionals' satisfaction will be explored using a mix of semi-structured open-ended interview questions.
The participants' and health care professionals' acceptability of the two different follow-up regimens.Acceptability of follow-up regimens from the baseline clinical visit to a clinical visit one year later.The participants' and health care professionals' acceptability of the two different follow-up regimens will be explored using a mix of semi-structured open-ended focus group questions.

Countries

Netherlands

Contacts

Primary ContactDominique C. Baas, PhD
dbaas@tergooi.nl0031-(0)887535153
Backup ContactLex D. de Jong, PhD
LDdeJong@Rijnstate.nl0031-(0)880058275

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026